Target cells were pretreated with the CDK inhibitor roscovitine [72], [73], MEK inhibitor U-0126 [74], or ERK inhibitor 5-iodotubercidin [75], [76] prior to infection with MHV68, and viral titers were evaluated by plaque assay at 24 h post-infection. The gene discussed is MAP2K7; the disease is infection.